Pharmacoeconomy in cancer therapy | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.10.2010 | Leading article

Pharmacoeconomy in cancer therapy

verfasst von: C. Dittrich

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Hepatocellular carcinoma – a challenge for oncologists

Nächster Artikel Robotic surgery in thoracic cancer

Titel: Pharmacoeconomy in cancer therapy
verfasst von: C. Dittrich
Publikationsdatum: 01.10.2010
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 3/2010
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-010-0212-9

Weitere Artikel der Ausgabe 3/2010

Analysis of exhaled breath for screening of lung cancer patients

Review

First- and second-line treatment strategies for chronic phase CML using tyrosine kinase inhibitors – present status discussed at ASH 2009

ASH report

Very low rates of neutropenic complications and chemotherapy dose modifications in early breast cancer patients receiving adjuvant FEC-100 or TAC and an individualised G-CSF and anti-infective support: results of a retrospective chart review

Original report

A review on biomolecular basis of the role of psychological stress in the development and progression of cancer

Review

Robotic surgery in thoracic cancer

Short review

Robotic surgery, a variant of minimally invasive surgery for gynaecological malignancies

Editorial